Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model

Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder for which effective treatment strategies are insufficient. Butyrate, a microbiota-derived short-chain fatty acid believed to strengthen the intestinal barrier function, might be a potential new treatment option. This study aimed...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mathias W. Scharf, Richard A. Forsgård, Samira B. R. Prado, John-Peter Ganda Mall, Dirk Repsilber, Robert J. Brummer, Tatiana M. Marques, Rebecca Wall
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
coleção:	Gut Microbes
Assuntos:	IBS intestinal barrier function in vivo Ussing chamber
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/19490976.2025.2545414
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!